GlassScriptPhysician profile
Kinneathea D Bennett
NPI 1902346141
$1,238.70
in general payments reported to CMS, 2019-2025
13 companies · $579 in 2025
The $579 reported for 2025 was more than what 75% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.51 · 2022: $461 · 2024: $182 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $252.74 | 2022-2025 | Arexvy, Ojjaara, Shingrix |
| Biotronik Nro, INC. | $132.78 | 2024 | Prospera |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2025 | Airsupra |
| Jazz Pharmaceuticals INC. | $123.74 | 2022 | |
| Seagen INC. | $117.41 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $100.39 | 2022 | |
| Angiodynamics, INC. | $93.46 | 2025 | Auryon Laser System 100-120 Vac |
| Teva Pharmaceuticals USA, INC. | $92.34 | 2025 | Austedo Xr |
| Amgen INC. | $90.47 | 2025 | Repatha |
| Abbvie INC. | $47.44 | 2024-2025 | |
| Incyte Corporation | $25.98 | 2024 | Opzelura |
| Exact Sciences Corporation | $20.45 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $16.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kinneathea Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.